Education Level and Long-term Mortality, Recurrent Stroke, and Cardiovascular Events in Patients With Ischemic Stroke.
cardiovascular events
education
ischemic stroke
mortality
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
18 08 2020
18 08 2020
Historique:
pubmed:
12
8
2020
medline:
10
3
2021
entrez:
12
8
2020
Statut:
ppublish
Résumé
Background Epidemiological studies have reported discrepant findings on the relationship between education level and outcomes after stroke. We aimed to prospectively investigate the relationship between education level and mortality, recurrent stroke, and cardiovascular events in Chinese patients with ischemic stroke. Methods and Results We included 3861 participants from the China Antihypertensive Trial in Acute Ischemic Stroke. Education level was categorized as illiteracy, primary school, middle school, and college. Study outcomes were all-cause mortality, stroke-specific mortality, recurrent stroke, and cardiovascular events within 2 years after ischemic stroke. A meta-analysis was conducted to incorporate the results of the current study and previous other studies on the association of education level with outcomes after stroke. Within 2 years after ischemic stroke, there were 327 (8.5%) all-cause deaths, 264 (6.8%) stroke-specific deaths, 303 (7.9%) recurrent strokes, and 364 (9.4%) cardiovascular events, respectively. The Kaplan-Meier curves showed that patients with the lowest education level had the highest cumulative incidence rates of all-cause mortality, stroke-specific mortality, and cardiovascular events (log-rank
Identifiants
pubmed: 32779506
doi: 10.1161/JAHA.120.016671
pmc: PMC7660803
doi:
Banques de données
ClinicalTrials.gov
['NCT01840072']
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e016671Références
BMC Public Health. 2006 Sep 11;6:227
pubmed: 16961936
Neuroepidemiology. 2019;53(1-2):27-31
pubmed: 30991387
BMJ Open. 2015 Jan 30;5(1):e005688
pubmed: 25636790
Stroke. 2017 Jun;48(6):1518-1523
pubmed: 28465458
Stroke. 2015 Mar;46(3):659-66
pubmed: 25649803
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
JAMA. 2014 Feb 5;311(5):479-89
pubmed: 24240777
Nature. 2016 May 11;533(7604):539-42
pubmed: 27225129
Hypertension. 2006 Jul;48(1):e3; author reply e5
pubmed: 16769991
Int J Stroke. 2014 Jun;9(4):429-36
pubmed: 23981768
Int J Stroke. 2012 Oct;7(7):E4
pubmed: 22989398
J Am Heart Assoc. 2020 Aug 18;9(16):e016671
pubmed: 32779506
Stroke Res Treat. 2012;2012:983145
pubmed: 22577605
Int J Stroke. 2016 Jul;11(5):557-64
pubmed: 27012272
Stroke. 2011 Jun;42(6):1658-64
pubmed: 21512182
Stroke. 2014 Dec;45(12):3556-60
pubmed: 25293659
Stroke. 2013 May;44(5):1232-7
pubmed: 23444308
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Stroke. 2011 Oct;42(10):2896-902
pubmed: 21817140
Lancet. 2019 Sep 28;394(10204):1145-1158
pubmed: 31248666
Lancet. 2020 Mar 7;395(10226):795-808
pubmed: 31492503
Stroke. 2005 Feb;36(2):310-4
pubmed: 15625296
Biometrics. 1994 Dec;50(4):1088-101
pubmed: 7786990
Int J Stroke. 2016 Apr;11(3):332-7
pubmed: 26780948
J Clin Hypertens (Greenwich). 2015 May;17(5):332-7
pubmed: 25703272
Stroke. 2012 Nov;43(11):2931-5
pubmed: 22935400
Nat Hum Behav. 2018 Feb;2(2):117-125
pubmed: 30406209
Am J Epidemiol. 2011 Oct 1;174(7):779-89
pubmed: 21813793
Stroke. 2001 Jul;32(7):1492-8
pubmed: 11441191
Circulation. 2015 Sep 1;132(9):873-98
pubmed: 26240271
Circulation. 2017 Feb 21;135(8):759-771
pubmed: 28052979
Eur J Prev Cardiol. 2017 Jul;24(10):1032-1042
pubmed: 28406328
Stroke. 2019 Apr;50(4):805-812
pubmed: 30852967
Lancet. 2015 Jan 10;385(9963):117-71
pubmed: 25530442
Lancet Neurol. 2006 Feb;5(2):181-8
pubmed: 16426994
Lancet Neurol. 2015 Dec;14(12):1206-18
pubmed: 26581971
Stroke. 1989 Jul;20(7):864-70
pubmed: 2749846
Stroke. 2016 Nov;47(11):2836-2842
pubmed: 27758939